DSIJ Mindshare

Key Highlights from SEBI's Latest Consultation Paper: Enhancing Trading Convenience and Strengthening Risk Monitoring in Equity Derivatives

These offerings provide investors with a structured way to participate in the growing IPO segment while also offering a well-diversified approach to investing in large- and mid-cap stocks.

The fixed-income market is at a crucial juncture, with multiple factors shaping SDLs as a preferred choice for fixed-income investors

These efforts, combined with improved financial performance, led to credit rating upgrades, with Acuité raising its rating by four notches to B+ (Stable Outlook) and CARE Ratings assigning a BB- (Stable Outlook).

Today's customers are more informed, and regulatory expectations for quality are higher than ever. Given these factors, I believe the Indian pharmaceutical industry is set for continued growth and global leadership, states Krishna Raghunathan, CFO of Supriya Lifescience Ltd.